Characterisation of atypical dMMR (deficient MisMatch Repair) tumours: a study from a large cohort of 4948 cases

被引：0
|
作者：
Selves, J. [1 ]
Jaffrelot, M. [1 ]
Laurenty, A. P. [2 ]
Fares, N. [3 ]
Icher, S. [1 ]
Brunac, A. C. [1 ]
Danjoux, M. [1 ]
Meilleroux, J. [1 ]
Toulas, C. [4 ]
Chipoulet, E. [4 ]
Staub, A. [5 ]
Guimbaud, R. [3 ]
机构：
[1] CHU IUCT ONCOPOLE, Toulouse, France
[2] Clin Croix Sud Toulouse, Toulouse, France
[3] CHU Toulouse, Toulouse, France
[4] Inst Claudius Regaud IUCT ONCOPOLE, Toulouse, France
[5] CH Montauban, Montauban, France
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-13-006
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [21] Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study
    Andre, T.
    Berton-Rigaud, D.
    Curigliano, G.
    Sabatier, R.
    Tinker, A. V.
    Oaknin, A.
    De Braud, F. G. M.
    Ellard, S.
    Arkenau, H-T.
    Trigo Perez, J. M.
    Brown, J.
    Jewell, A.
    Pikiel, J.
    Mirza, M. R.
    Duan, T.
    Antony, G.
    Zildjian, S.
    Zografos, E.
    Veneris, J.
    Banerjee, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S799 - S800
  • [22] INTERIM RESULTS OF A PHASE 2 STUDY OF NIVOLUMAB AND RELATLIMAB IN ADVANCED MISMATCH REPAIR DEFICIENT (DMMR) CANCERS RESISTANT TO PRIOR PD-(L)1 INHIBITION
    Bever, Katherine
    Wang, Hao
    Durham, Jennifer
    Apostol, Colleen
    Azad, Nilofer
    Browner, Ilene
    Gaillard, Stephanie
    Laheru, Daniel
    Lee, Valerie
    Sharfman, William
    Yarchoan, Mark
    Zhu, Qingfeng
    Anders, Robert
    Pardoll, Andrew
    Topalian, Suzanne
    Llosa, Nicolas
    Jaffee, Elizabeth
    Le, Dung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A744 - A744
  • [23] PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY
    Baldini, Capucine
    Cassier, Philippe A.
    Delord, Jean-Pierre
    Simonelli, Matteo
    Touat, Mehdi
    Yao, Lili
    Duic, J. Paul
    Gozman, Alexander
    Marabelle, Aurelien
    NEURO-ONCOLOGY, 2022, 24 : 59 - 60
  • [24] Prominent Schlafen 11 expression associates with right-sided, mismatch repair-deficient colorectal carcinomas - a study of 3300 tumours
    Kaczorowski, M.
    Chlopek, M.
    Daum, O.
    Michal, M.
    Kowalik, A.
    Lasota, J.
    Miettinen, M.
    VIRCHOWS ARCHIV, 2024, 485 : S27 - S28
  • [25] An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
    Han, Bogyeong
    Kim, Sehui
    Koh, Jiwon
    Bae, Jeong Mo
    Yun, Hongseok
    Jeon, Yoon Kyung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) : 92 - 96
  • [26] Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLε)-mutated solid tumours in the GARNET study
    Samuel, L.
    Miller, R.
    Ross, P.
    Arkenau, T.
    Antony, G.
    Veneris, J.
    Rule, J.
    Starling, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S73 - S74
  • [27] Safety and antitumor activity of dostarlimab in patients (pts) with advanced or recurrent DNA mismatch repair deficient (dMMR) or proficient (MMRp) endometrial cancer (EC): Results from GARNET
    Oaknin, A.
    Gilbert, L.
    Tinker, A. V.
    Sabatier, R.
    Boni, V.
    O'Malley, D. M.
    Ghamande, S.
    Duska, L.
    Ghatage, P.
    Guo, W.
    Im, E.
    Pothuri, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S1166 - S1166
  • [28] Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.
    Puccini, Alberto
    Rossini, Daniele
    Dapra, Valentina
    Schietroma, Francesco
    Perazzo, Serena
    Ceccarelli, Anna
    Zoratto, Federica
    Costantini, Manuel
    Formica, Vincenzo
    Rofei, Michela
    Mauri, Gianluca
    Bonazzina, Erica
    Tamburini, Emiliano
    Signorelli, Carlo
    Antonuzzo, Lorenzo
    Damonte, Camilla
    Spinelli, Antonino
    Tortora, Giampaolo
    Santoro, Armando
    Salvatore, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Outcome of chemotherapy with or without targeted therapy in metastatic colorectal cancer with deficient mismatch repair phenotype: A cohort study in a single center
    Yu, Yue
    Zeng, Yi-Xin
    Ying, Jianming
    Zhang, Wen
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study
    Gkekas, Ioannis
    Jan, Novotny
    Kaprio, Tuomas
    Beilmann-Lehtonen, Ines
    Fabian, Pavel
    Tavelin, Bjorn
    Bockelman, Camilla
    Edin, Sofia
    Strigard, Karin
    Svoboda, Tomas
    Hagstrom, Jaana
    Barsova, Lucie
    Jirasek, Tomas
    Haglund, Caj
    Palmqvist, Richard
    Gunnarsson, Ulf
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (07) : 1295 - 1304
12345